Our case report may represent a treatment option for patients withtreatment-resistant schizophrenia, who display partial responses to clozapine and face the risk of developing a metabolic syndrome. This effective, though extreme, polypharmacy of treatment-resistant schizophrenia require further evidence and confirmative data and should be used only in severe, selected cases, with the full consent and compliance of patients.
Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.
TOFFANIN, TOMMASO;PERINI, GIULIA
2009
Abstract
Our case report may represent a treatment option for patients withtreatment-resistant schizophrenia, who display partial responses to clozapine and face the risk of developing a metabolic syndrome. This effective, though extreme, polypharmacy of treatment-resistant schizophrenia require further evidence and confirmative data and should be used only in severe, selected cases, with the full consent and compliance of patients.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
